Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

NCT01983449 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Diseases

Interventions

DRUG: Dexamethasone Sodium Phosphate Injection, USP

Sponsor

Mercator MedSystems, Inc.